A Comprehensive Solution for in vitro Cardiac Safety Assessment.
The xCELLigence RTCA CardioECR System is the first ever platform to combine impedance and field potential recording for simultaneous and noninvasive measurement of integrated ion channel activity and contractility of cardiomyocytes in a 48 well microtiter plate format. The system is designed to be placed in a standard tissue culture incubator with physiological temperature, CO2 level and humidity, allowing better controlled assays with both short-term and long-term measurements in real-time.
Features:
Manufacturer OLS OMNI Life Science | Available Worldwide
Be the first to review this product